Location History:
- Shizuoka, JP (2016)
- Hamamatsu, JP (1994 - 2022)
Company Filing History:
2 out of 7 
2 out of 43 
1 out of 108 
Years Active: 1994-2022
Title: Naohiro Kanayama: Innovator in Cytocidal Agents
Introduction
Naohiro Kanayama is a prominent inventor based in Hamamatsu, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of cytocidal agents. With a total of five patents to his name, Kanayama's work focuses on innovative peptide drugs that target abnormal cell proliferation.
Latest Patents
Kanayama's latest patents include a cytocidal agent that features a peptide with a specific amino acid sequence. This agent is designed to selectively induce apoptosis in target cells. The invention includes a fusion peptide that combines an endosome escape peptide with an apoptosis-inducing peptide. This innovative approach aims to provide a therapeutic solution for diseases caused by the abnormal proliferation of cells.
Career Highlights
Throughout his career, Naohiro Kanayama has worked with esteemed institutions such as Fujita Academy and Hamamatsu University School of Medicine. His research has been pivotal in advancing the understanding of peptide drugs and their applications in medicine.
Collaborations
Kanayama has collaborated with notable colleagues, including Kazuhiro Sugihara and Toshiaki Shibata. These partnerships have contributed to the success of his research and the development of his patented technologies.
Conclusion
Naohiro Kanayama's innovative work in the field of cytocidal agents showcases his dedication to advancing medical science. His contributions through patents and collaborations highlight the importance of research in developing effective therapeutic solutions.